2020
Screening Breast Ultrasound: Update After 10 Years of Breast Density Notification Laws.
Butler RS, Hooley RJ. Screening Breast Ultrasound: Update After 10 Years of Breast Density Notification Laws. American Journal Of Roentgenology 2020, 214: 1424-1435. PMID: 32182096, DOI: 10.2214/ajr.19.22275.Peer-Reviewed Original Research
2019
Optoacoustic Imaging and Gray-Scale US Features of Breast Cancers: Correlation with Molecular Subtypes.
Dogan BE, Menezes GLG, Butler RS, Neuschler EI, Aitchison R, Lavin PT, Tucker FL, Grobmyer SR, Otto PM, Stavros AT. Optoacoustic Imaging and Gray-Scale US Features of Breast Cancers: Correlation with Molecular Subtypes. Radiology 2019, 292: 564-572. PMID: 31287388, DOI: 10.1148/radiol.2019182071.Peer-Reviewed Original ResearchConceptsBreast cancer molecular subtypesHuman epidermal growth factor receptorLuminal breast cancerCancer molecular subtypesUS featuresEpidermal growth factor receptorMolecular subtypesGrowth factor receptorBreast cancerProspective multi-institutional studyFactor receptorLogistic regression analysisMulti-institutional studyLogistic regression modelsMultinomial logistic regression analysisGray-scale USMultinomial logistic regression modelsImmunohistochemistry findingsMean ageInvasive cancerPathologic diagnosisPathology reportsUS scoreKruskal-Wallis testCancer subtypes
2013
Where does radioimmunotherapy fit in the management of breast cancer?
Doddamane I, Butler R, Jhaveri A, Chung GG, Cheng D. Where does radioimmunotherapy fit in the management of breast cancer? Immunotherapy 2013, 5: 895-904. PMID: 23902558, DOI: 10.2217/imt.13.78.Peer-Reviewed Original ResearchConceptsMetastatic breast cancerBreast cancerSelection of patientsMultiple organ involvementSolitary metastatic lesionUnpredictable clinical behaviorDifferent clinical presentationsCurative optionOrgan involvementClinical presentationMetastatic lesionsClinical behaviorHeterogeneous diseaseCurrent managementPrognostic modelCancerBiological heterogeneityMain causePatientsMalignancyLesionsRadioimmunotherapyDiseaseWomenBreast imaging of the pregnant and lactating patient: physiologic changes and common benign entities.
Vashi R, Hooley R, Butler R, Geisel J, Philpotts L. Breast imaging of the pregnant and lactating patient: physiologic changes and common benign entities. American Journal Of Roentgenology 2013, 200: 329-36. PMID: 23345354, DOI: 10.2214/ajr.12.9845.Peer-Reviewed Original ResearchConceptsPhysiologic changesCommon benign breast diseasesPregnancy-associated breast cancerBenign breast diseaseCommon benign entitiesBenign breast abnormalitiesBreast diseaseImaging featuresBenign entityPatient managementBreast cancerBreast abnormalitiesBreast imagingPregnancyHistologicCancerAbnormalitiesBreastDiseaseBreast imaging of the pregnant and lactating patient: imaging modalities and pregnancy-associated breast cancer.
Vashi R, Hooley R, Butler R, Geisel J, Philpotts L. Breast imaging of the pregnant and lactating patient: imaging modalities and pregnancy-associated breast cancer. American Journal Of Roentgenology 2013, 200: 321-8. PMID: 23345353, DOI: 10.2214/ajr.12.9814.Peer-Reviewed Original Research3.0 Tesla vs 1.5 Tesla breast magnetic resonance imaging in newly diagnosed breast cancer patients
Butler RS, Chen C, Vashi R, Hooley RJ, Philpotts LE. 3.0 Tesla vs 1.5 Tesla breast magnetic resonance imaging in newly diagnosed breast cancer patients. World Journal Of Radiology 2013, 5: 285-294. PMID: 24003354, PMCID: PMC3758496, DOI: 10.4329/wjr.v5.i8.285.Peer-Reviewed Original ResearchPositive predictive valueHigh positive predictive valueBreast cancer patientsSuspicious lesionsT groupAdditional malignanciesT MR examinationsCancer patientsAdditional cancersBreast cancerExact testAccountability Act-compliant retrospective reviewMR examinationsInstitutional review board approvalBreast magnetic resonanceFisher's exact testMR imaging studiesReview board approvalNeoadjuvant chemotherapyIndex cancerContralateral breastRetrospective reviewT MR imagingBiopsy resultsPathologic diagnosis
2012
Screening US in Patients with Mammographically Dense Breasts: Initial Experience with Connecticut Public Act 09-41
Hooley RJ, Greenberg KL, Stackhouse RM, Geisel JL, Butler RS, Philpotts LE. Screening US in Patients with Mammographically Dense Breasts: Initial Experience with Connecticut Public Act 09-41. Radiology 2012, 265: 59-69. PMID: 22723501, DOI: 10.1148/radiol.12120621.Peer-Reviewed Original ResearchConceptsPositive predictive valueOverall positive predictive valueBI-RADS category 4BI-RADS category 3Breast ultrasonographyDense breastsBreast cancerOverall cancer detection rateHIPAA-compliant retrospective reviewData System (BI-RADS) category 1Occult breast cancerCancer detection rateWhole-breast ultrasonographyCategory 4Category 3Dense breast tissueBreast Imaging ReportingPostmenopausal patientsIntermediate riskRetrospective reviewRisk groupsUS examinationHigh riskGeneral populationLower risk